THE CONCEPT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE CLINICAL CONTROL AS A DECISION - MAKING TOOL IN REAL CLINICAL PRACTICE FOR OPTIMIZING OF BASIC PHARMACOTHERAPY ArticleAvdeev S.N., Aisanov Z.R., Belevsky A.S., Beeh K.M., Vizel A.A., Zyryanov S.K., Ignatova G.L., Kostikas K., Leshchenko I.V., Ovcharenko S.I., Sinopal'nikov A.I., Titova O.N., Shmelev E.I.Terapevticheskii Arkhiv. Том 92. 2020. С. 89-95
PHARMACOECONOMIC EFFICACY OF ATESOLIZUMAB COMPARED WITH OTHER PD-1 INHIBITORS IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER AFTER CHEMOTHERAPY ArticleZyryanov S.K., Diyakov I.N.FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Том 13. 2020. С. 5-12
TREATMENT MANAGEMENT BASED ON ADHERENCE: PATIENT RECOMMENDATION ALGORITHMS. CROSS-DISCIPLINARY GUIDELINES ArticleНиколаев Н.А., Мартынов А.И., Скирденко Ю.П., Анисимов В.Н., Васильева И.А., Виноградов О.И., Лазебник Л.Б., Поддубная И.В., Ройтман Е.В., Агеев Ф.Т., Андреев К.А., Бабичева Л.Г., Бунова С.С., Викторова И.А., Волчегорский И.А., Галявич А.С., Гаус О.В., Гомберг В.Г., Горбенко А.В., Драпкина О.М. ...Medical News of North Caucasus. Том 15. 2020. С. 461-468
GUIDELINES OF THE ASSOCIATION OF ANESTHESIOLOGISTS-INTENSIVISTS, THE INTERREGIONAL NON-GOVERNMENTAL ORGANIZATION ALLIANCE OF CLINICAL CHEMOTHERAPISTS AND MICROBIOLOGISTS, THE INTERREGIONAL ASSOCIATION FOR CLINICAL MICROBIOLOGY AND ANTIMICROBIAL CHEMOTHERAPY (IACMAC), AND NGO RUSSIAN SEPSIS FORUM DIAGNOSTICS AND ANTIMICROBIAL THERAPY OF THE INFECTIONS CAUSED BY MULTIRESISTANT MICROORGANISMS ArticleBeloborodov V.B., Gusarov V.G., Dekhnich A.V., Zamyatin M.N., Zubareva N.A., Zyryanov S.K., Kamyshova D.A., Klimko N.N., Kozlov R.S., Kulabukhov V.V., Polushin Y.S., Rudnov V.A., Sidorenko S.V., Shlyk I.V., Edelshtein M.V., Yakovlev S.V.Вестник анестезиологии и реаниматологии. Том 17. 2020. С. 52-83
LIPID-LOWERING THERAPY IN OUTPATIENTS OF DIFFERENT AGES WITH CORONARY ARTERY DISEASE ArticleZyryanov S.K., Fitilev S.B., Vozzhaev A.V., Shkrebneva I.I., Landyshev N.N., Voronko Ya.G., Lutsenko A.M.Cardiovascular Therapy and Prevention. Том 19. 2020. С. 75-82
DEVELOPMENT AND VALIDATION OF A QUANTITATIVE DETERMINATION METHOD FOR MEROPENEM IN BLOOD PLASMA FOR THERAPEUTIC DRUG MONITORING ArticleKazanova A.M., Stepanova E.S., Makarenkova L.M., Chistyakov V.V., Zyryanov S.K., Senchenko S.P.Pharmaceutical Chemistry Journal. Том 54. 2020. С. 414-418
OVERVIEW OF ANTICONVULSANT THERAPY IN FULL-TERM AND PREMATURE NEONATES ArticleИвжиц М.А., Зырянов С.К., Родоман Г.В., Бондарева И.Б., Думова С.В., Бабак О.А., Ченкуров М.С., Пуцман Г.А.Russkii Zhunal Detskoi Nevrologii. Том 15. 2020. С. 42-54
MURAMYLDIPEPTIDE - BASED COMPOUNDS IN CURRENT MEDICINE: FOCUS ON GLUCOSAMINYLMURAMYL DIPEPTIDE ArticleUshkalova E.A., Zyryanov S.K., Zatolochina K.E.Terapevticheskii Arkhiv. Том 91. 2019. С. 122-127
MODELING OF THE IMPACT OF BIOLOGICAL DRUGS IN THE ECONOMIC BURDEN OF SEVERE ASTHMA ArticleZyryanov Sergey, Dyakov Ilya, Karpov OlegКачественная клиническая практика. 2019. С. 4-12
POTENTIALLY PRESCRIBING OMISSIONS IN ELDERLY PATIENTS: PREVALENCE, RISK FACTORS AND IDENTIFICATION ArticleAl-Ragawi Ali, Zyryanov SergeySCIENCE4HEALTH 2019. Клинические и теоретические аспекты современной медицины. 2019. 146 с.
COMPARATIVE PHARMACOECONOMICS OF BX IN THE TREATMENT OF PATIENTS WITH UNCONTROLLED MODERATE AND SEVERE ATOPIC ASTHMA IN THE RUSSIAN HEALTH CARE SETTING ArticleZyryanov S., Dyakov I.Value in Health. Том 22. 2019.
PARAPROCTITIS: ETIOLOGY AND CURRENT FEATURES OF PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS ArticleRodoman G.V., Zyryanov S.K., Ivzhits M.A., Romashov O.M., Alexandrov M.I., Putsman G.A., Ionidi P.V.Хирург. 2019. С. 40-49
MEDICATION ERRORS ASSOCIATED WITH BETA-LACTAM ANTIBIOTICS: ANALYSIS OF RUSSIAN SPONTANEOUS REPORTING DATABASE ArticleKuzmina A.V., Asetskaya I.L., Polivanov V.A., Zyryanov S.K.Antibiotiki i Khimioterapiya. Том 64. 2019. С. 48-53
DISCREPANCIES IN DRUG LABELING TEXTS AS A CAUSE OF MEDICATION ERRORS ArticleAsetskaya I.L., Polivanov V.A., Zyryanov S.K., Glagolev S.V., Kuzmina A.V.Вестник Росздравнадзора. 2019. С. 59-62
ABDOMINAL INFECTION. ANALYSIS, COMPARISON AND APPROACHES TO ANTIBIOTIC THERAPY: RUSSIAN AND INTERNATIONAL EXPERIENCE AND RECOMMENDATIONS ArticleRodoman G.V., Zyryanov S.K., Romashov O.M., Ivzhits M.A., Putsman G.A., Ionidi P.V., Kosenko O.A., Chenkurov M.S.Хирург. 2019. С. 45-59
CLINICAL AND ECONOMIC EFFICIENCY OF TREATMENT WITH CARIPRAZINE IN SCHIZOPHRENIA ArticleDyakov I.N., Zyryanov S.K.Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova. Том 119. 2019. С. 66-77
ECONOMIC PERSPECTIVES FOR EFFECTIVE CONTROL OF DIABETES MELLITUS TYPE 2 WITH FIXED COMBINATION OF BASAL INSULIN ANALOG AND GLP-1 AGONIST ArticleZyryanov S.K., Dyakov I.N.Качественная клиническая практика. 2019. С. 4-14
GENERICS AND BIOSIMILARS IN ONCOLOGY ArticleGopienko I.A., Ushkalova E.A., Zyryanov S.K.Качественная клиническая практика. 2019. С. 15-22
ANALYSIS OF ADVERSE DRUG REACTIONS IN ELDERLY PATIENTS ACCORDING TO THE DATABASE OF SPONTANEOUS REPORTS ArticleZatolochina K.E., Ushkalova E.A., Zyryanov S.K., Polivanov V.A.Хирург. 2019. С. 69-73
AVAILABILITY OF PHARMACOTHERAPY FOR BRONCHIAL ASTHMA WITH REGARD TO THE PHENOTYPE IN THE HOSPITAL: AN ANALYSIS OF ROUTINE PRACTICE ArticleIvanov Dmitriy, Butranova O.I., Zyryanov S.K.SCIENCE4HEALTH 2019. Клинические и теоретические аспекты современной медицины. 2019. 91 с.
THE PHARMACOKINETIC OF THE MAIN ORAL ANTIBIOTICS IN CHILDREN WITH CYSTIC FIBROSIS ArticleKondakova Y., Kondratyeva E., Zyryanov S., Bondareva I., Sherman V., Melyanovskaya Y.EUROPEAN RESPIRATORY JOURNAL. Том 54. 2019.
ФАРМАКОНАДЗОР MonographKolbin A.S., Kolbin A.S., Zyryanov S.K., Zyryanov S.K., Belousov D.Yu., Belousov D.Yu., Логиновская О.А., Матвеев А.В., Romanov B.K., Глаголев С.В., Plavinsky S.L., Burbello A.T., Zagorodnikova K.A., Karpenko L.I.ОКИ: Буки-Веди. 2019. 248 с.
ВОЗРАСТНЫЕ ОСОБЕННОСТИ ФАРМАКОКИНЕТИКИ ЦИПРОФЛОКСАЦИНА У ДЕТЕЙ, БОЛЬНЫХ МУКОВИСЦИДОЗОМ ArticleКондратьева Е.И., Кондакова Ю.А., Зырянов С.К., Бондарева И.Б., Воронкова А.Ю., Шерман В.Д., Мельяновская Ю.Л.Клиническая микробиология и антимикробная химиотерапия. Том 21. 2019. 37 с.
THE USE OF NEW DOSAGE FORMS OF ANTIBIOTICS AS A WAY TO IMPROVE THE EFFECTIVENESS AND SAFETY OF ANTIBIOTIC THERAPY ArticleZyryanov S.K., Baibulatova E.A.Antibiotiki i Khimioterapiya. Том 64. 2019. С. 81-91
MODERN APPROACHES TO THE RATIONAL CHOICE OF ANTIBIOTIC FOR TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN VARIOUS CATEGORIES OF PATIENTS ArticleZyryanov S.K., Butranova O.I.Качественная клиническая практика. 2019. С. 89-105